CIK: 1688327 - Address: C/O Third Rock Ventures, LLC, 201 Brookline Ave, Suite 1401, Boston, MA 02215
3 results

TC

Stat

Stk

Ins

Fil

+d

+w

+m

+q

+h

+y

avg

Filing Date

T Date

Ticker

Issuer

Inc

Sector

Ind

Industry

Owner

oSt

Rel

Title

T

TVal

Price

L

Qty

oc

Own

H

r2y

r1y

r6m

r3m

r6w

r3w

r7d

r3d

f1d

f1w

f1m

f3m

f6m

f1y

2/21/24 17:52
2/20/24
TNGXTango Therapeutics, Inc.DEHealthDrugPharmaceutical PreparationsThird Rock Ventures Iv, L.P.MATS-1,95012.000-163-119,201D
2/9/23 16:30
2/7/23
MGTAMagenta Therapeutics, Inc.DEHealthDrugPharmaceutical PreparationsThird Rock Ventures Iv, L.P.MATS.m-3,0560.82590-3,700-553,058D
7/22/19 16:38
7/22/19
FULCFulcrum Therapeutics, Inc.DEHealthDrugPharmaceutical PreparationsThird Rock Ventures Iv, L.P.MATP.d1,30016.0008142,343D

DDerivative transaction in filing (usually option exercise)
MMultiple transactions in filing; earliest reported transaction date and weighted average transaction price
AAmended filing
EError detected in filing
S - SaleSale of securities on an exchange or to another person
S - Sale+OESale of securities on an exchange or to another person (after option exercise)
F - TaxPayment of exercise price or tax liability using portion of securities received from the company
P - PurchasePurchase of securities on an exchange or from another person
Return to top

Contact